Introducción: En nuestro laboratorio hemos desarrollado implantes subcutáneos de carvedilol capaces de mantener niveles plasmáticos sostenidos del β-bloqueante durante 3 semanas. Objetivo: Evaluación de la liberación in vivo y la eficacia cardioprotectora de implantes subcutáneos de carvedilol desarrollados con poliepsilon- caprolactona (PCL) y ...
Miguel Angel Allo +7 more
openaire +2 more sources
Peculiarities of multidrug-resistant tuberculosis on the background of idiopathic pulmonary fibrosis (a clinical case report) [PDF]
Objective – familiarization of practitioners with the peculiarities of pulmonary multi-drug resistant tuberculosis (MDRT) in a patient with idiopathic pulmonary fibrosis (IPF) resulted from a long exposure to environmental factors at the workplace ...
A. V. Fedorets +4 more
core +2 more sources
Latvijas Zinātņu akadēmijas akadēmiķe profesore Vija Zaiga Kluša : biobibliogrāfija II / Latvijas Universitātes Akadēmiskā bibliotēka; sast. Dagnija Ivbule; korektore Gita Bērziņa; maketu veidojusi Baiba Lazdiņa.
Ivbule, Dagnija +1 more
core
Menores niveles circulantes del péptido vasoactivo y cardioprotector angiotensina-(1-9) en pacientes con hipertension arterial pulmonar [PDF]
Resumen: Introducción: La vía clásica del sistema renina-angiotensina (SRA) está activado en pacientes con hipertensión arterial pulmonar (HAP). Previamente, hemos encontrado que en la disfunción ventricular post infarto al miocardio experimental la activación del eje clásico del SRA, dado por la enzima convertidora de angiotensina I (ECA) y ...
Ocaranza, María Paz +6 more
openaire +2 more sources
METABOLIC CARDIOPROTECTOR THERAPY IN PEDIATRIC SPORTS MEDICINE
Our previous studies have demonstrated the importance of early diagnostics and treatment of pathological cardiac transformations in young athletes. The present pilot clinical study is focused on cardioprotective effects of 2-ethyl-6-methyl-3-oxy-pyridine succinate (“Mexicor”, EcoPharmInvest) in young athletes with stress cardiomyopathy.
L. A. Balykova +5 more
openaire +1 more source
Background. The condition of prediabetes implies the possibility to achieve stable normal glycemic indicators in order to prevent the further development of diabetes without using drug therapy.
G. Myhalchyshyn +2 more
doaj +1 more source
Механізми впливу препарату АТФ-лонг на працездатність тварин при експериментальному моделюванні фізичних навантажень [PDF]
Проблема погіршення функціонального стану серцево-судинної системи за інтенсивних фізичних навантажень є однією з найважливіших проблем спортивної медицини, кардіології та фармакології.
Безугла, В.В. +4 more
core
Experimental approaches to the assessment of potential cardioprotective means with doxorubicin-associated cardiomyopathy [PDF]
Development of methodological approaches for evaluation of cardioprotective activity of drugs in doxorubicin ...
Danilenko, L. M. +4 more
core
Дослідження кардіопротекторних властивостей густого екстракту «Кардіоcтен». [PDF]
Topicality. For treatment of cardiovascular diseases vegetative origin pharmacological preparations with metabolic and cytoprotective effects are increasingly used, but their range is rather limited.
Galuzinska, L. V. +3 more
core +2 more sources
METABOLITHOTROPIC ASPECTS OF CARDIOPROTECTIVE ACTION OF NEW COMBINED MEDICINE BASED ON L-ARGININE AND THIOTRIAZOLIN AT MODELING OF MYOCARDIAL INFARCTION [PDF]
  Objectives: The actual problem of modern medicine is the development of medications in treatment of cardiovascular system diseases. Different combinations of L-arginine with thiotriazolin in acute myocardial ischemia were examined as part of study ...
Antonovich, Mazur Ivan +3 more
core +1 more source

